Prescribing analysis publications

Monthly reports on the carbon footprint of inhaler use within primary care in Wales.

AWTTC have developed the following annual prescribing reports for health boards in Wales. These are individualised, comparative reports that give the health board's ranking and progress with regard to a series of measures in relation to the other health boards.

This paper is intended to inform AWMSG of progress made in monitoring the usage of medicines appraised by AWMSG and the National Institute for Health and Care Excellence (NICE).

This document has been prepared by the Welsh Analytical Prescribing Support Unit (WAPSU) to provide a detailed analysis of diabetes therapeutic area prescribing at national, health board and GP cluster level.

These documents have been prepared by the Welsh Analytical Prescribing Support Unit (WAPSU) to support the tramadol educational resource materials, endorsed by AWMSG in November 2013.

This paper provides an analysis of primary care prescribing in Wales and England for medicines and preparations within the respiratory therapeutic area for the period July 2013–June 2014.

This report outlines a proposed method for the development of cluster group comparators, based on socio-economic similarity and disease prevalence, to enable benchmarking of prescribing.